A Case of Atrial Fibrillation and Rapid Ventricular Response in a 22-Year-Old Athlete With Sickle Cell Trait

Sickle cell trait (SCT) is generally regarded as a benign carrier state of sickle cell disease (SCD); however, emerging evidence indicates that it may be associated with adverse cardiovascular outcomes, including atrial fibrillation (AF). AF is uncommon among young, otherwise healthy athletes, and its occurrence in individuals with SCT is not extensively documented. We present a case involving a 22-year-old male collegiate football player with a history of SCT who presented with palpitations initiated during practice. Upon arrival, he was hemodynamically stable; nonetheless, his initial electrocardiogram (ECG) revealed atrial fibrillation with rapid ventricular response (AF RVR). Laboratory investigations were unremarkable, including a normal troponin level. The patient was administered intravenous (IV) diltiazem for rate control, and synchronized cardioversion was successfully performed to restore sinus rhythm. Short-term anticoagulation therapy with apixaban was prescribed, along with flecainide on an as-needed basis for rhythm management. The patient was subsequently referred for outpatient catheter ablation and placed on a three-month restriction from contact sports. This case underscores a rare presentation of AF RVR in a young athlete with SCT. Exertional stress may contribute to arrhythmogenesis through mechanisms such as vaso-occlusion, hypoxia, acidosis, and dehydration. Current guidelines recommend rate control, cardioversion when clinically indicated, and short-term anticoagulation in cases of new-onset AF. Catheter ablation presents a potential definitive therapeutic option for young, symptomatic individuals. Preventive measures for athletes with SCT should include adequate hydration, heat acclimatization, and education of players and coaching staff. This case highlights the importance of heightened awareness, adherence to guideline-based management, and the necessity for further research into the association between SCT and AF in young athletes.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-10-26
DOI
https://doi.org/10.7759/cureus.95437
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Case of Atrial Fibrillation and Rapid Ventricular Response in a 22-Year-Old Athlete With Sickle Cell Trait

Robert E. Jordan, THAD MOSELEY, Matthew D Overturf, Steven M Sasser
Cureus
Hemoglobinopathies and Related Disorders
article

A Case of Atrial Fibrillation and Rapid Ventricular Response in a 22-Year-Old Athlete With Sickle Cell Trait

Robert E. Jordan, THAD MOSELEY, Matthew D Overturf, Steven M Sasser
article en

Abstract

Sickle cell trait (SCT) is generally regarded as a benign carrier state of sickle cell disease (SCD); however, emerging evidence indicates that it may be associated with adverse cardiovascular outcomes, including atrial fibrillation (AF). AF is uncommon among young, otherwise healthy athletes, and its occurrence in individuals with SCT is not extensively documented. We present a case involving a 22-year-old male collegiate football player with a history of SCT who presented with palpitations initiated during practice. Upon arrival, he was hemodynamically stable; nonetheless, his initial electrocardiogram (ECG) revealed atrial fibrillation with rapid ventricular response (AF RVR). Laboratory investigations were unremarkable, including a normal troponin level. The patient was administered intravenous (IV) diltiazem for rate control, and synchronized cardioversion was successfully performed to restore sinus rhythm. Short-term anticoagulation therapy with apixaban was prescribed, along with flecainide on an as-needed basis for rhythm management. The patient was subsequently referred for outpatient catheter ablation and placed on a three-month restriction from contact sports. This case underscores a rare presentation of AF RVR in a young athlete with SCT. Exertional stress may contribute to arrhythmogenesis through mechanisms such as vaso-occlusion, hypoxia, acidosis, and dehydration. Current guidelines recommend rate control, cardioversion when clinically indicated, and short-term anticoagulation in cases of new-onset AF. Catheter ablation presents a potential definitive therapeutic option for young, symptomatic individuals. Preventive measures for athletes with SCT should include adequate hydration, heat acclimatization, and education of players and coaching staff. This case highlights the importance of heightened awareness, adherence to guideline-based management, and the necessity for further research into the association between SCT and AF in young athletes.

CureusVol. 17(10)
Edward Via College of Osteopathic Medicine (US)
Openalex Percentile: Top 58%
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.